Check out our full press release here for more details. Earlier this week, we announced a new instrument collaboration with Kytopen, a leader in the development and commercialization of non-viral transfection tools for genome engineering. This partnership brings the power of Ganymede’s Lab-as-Code™ platform to Kytopen’s products: * The
At some point, every biotech and pharma lab faces the same question when it comes to integrating data from their analytical instruments: should I buy software or build something in-house? Usually, this question comes up when a lab hits a certain critical mass of workflows, instruments, and staff. The amount
Our co-founder, Nathan Clark, sat down with The Scale Up Show's Ryan Staley at the end of last year for a conversation on entrepreneurship and the future of software and AI in biotech that's suddenly very timely. The broad rollout of generative AI tools like ChatGPT has many thinking about
A new installment in our "Meet the Team" series.
Because your flow cytometry analysis should be as colorful as your stained cells.
Automation and lab data connectivity are creating haves and have-nots in the biotech space. There are no guides for how to assemble the right data infrastructure nor how to invest your resources in data technologies. So far, the closest we've gotten as an industry to a "guide" is a rough
At Ganymede, our core focus is on creating 10X scientists. We use our expertise in cloud infrastructure to give you and your team data superpowers. Automation has historically been transformational for scaling up experiments. Think advanced robotics, liquid handlers, and workcells. But, when it comes to analyzing that data, there